BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 37257234)

  • 21. Racial, ethnic and socioeconomic disparities in SARS-CoV-2 infection amongst children.
    Mannheim J; Konda S; Logan LK
    Paediatr Perinat Epidemiol; 2022 May; 36(3):337-346. PubMed ID: 35076946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Cardiovascular Complications in Individuals with Sickle Cell Anemia and Other Hemoglobinopathies: A Systematic Review.
    Lopes A; Dantas MT; Ladeia AMT
    Arq Bras Cardiol; 2022 Dec; 119(6):893-899. PubMed ID: 36417618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
    Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
    JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
    Vahidy FS; Nicolas JC; Meeks JR; Khan O; Pan A; Jones SL; Masud F; Sostman HD; Phillips R; Andrieni JD; Kash BA; Nasir K
    BMJ Open; 2020 Aug; 10(8):e039849. PubMed ID: 32784264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current tobacco smoking and risk of SARS-CoV-2 infection and hospitalization: Evaluating the role of socio-demographic factors and comorbidities.
    Young-Wolff KC; Slama N; Sakoda LC; Prochaska JJ; Fogelberg R; Alexeeff SE
    Prev Med; 2023 Jul; 172():107523. PubMed ID: 37116761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England.
    Saatci D; Ranger TA; Garriga C; Clift AK; Zaccardi F; Tan PS; Patone M; Coupland C; Harnden A; Griffin SJ; Khunti K; Dambha-Miller H; Hippisley-Cox J
    JAMA Pediatr; 2021 Sep; 175(9):928-938. PubMed ID: 34152371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Lines That Held Us: Assessing Racial and Socioeconomic Disparities in SARS-CoV-2 Testing.
    Hsiao CJ; Patel AGM; Fasanya HO; Stoffel MR; Beal SG; Winston-McPherson GN; Campbell ST; Cotten SW; Crews BO; Kuan K; Lapedis CJ; Mathias PC; Peck Palmer OM; Greene DN
    J Appl Lab Med; 2021 Sep; 6(5):1143-1154. PubMed ID: 34240171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities in SARS-CoV-2 Positivity Rates: Associations with Race and Ethnicity.
    Kaufman HW; Niles JK; Nash DB
    Popul Health Manag; 2021 Feb; 24(1):20-26. PubMed ID: 32985959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust Testing in Outpatient Settings to Explore COVID-19 Epidemiology: Disparities in Race/Ethnicity and Age, Salt Lake County, Utah, 2020.
    Ahmed SM; Shah RU; Fernandez V; Grineski S; Brintz B; Samore MH; Ferrari MJ; Leung DT; Keegan LT
    Public Health Rep; 2021 May; 136(3):345-353. PubMed ID: 33541222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social Vulnerability and Rurality Associated With Higher Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Induced Seroprevalence: A Nationwide Blood Donor Study-United States, July 2020-June 2021.
    Li Z; Lewis B; Berney K; Hallisey E; Williams AM; Whiteman A; Rivera-González LO; Clarke KEN; Clayton HB; Tincher T; Opsomer JD; Busch MP; Gundlapalli AV; Jones JM
    Clin Infect Dis; 2022 Aug; 75(1):e133-e143. PubMed ID: 35137014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-based surveillance for selected hemoglobinopathies.
    Hulihan MM; Feuchtbaum L; Jordan L; Kirby RS; Snyder A; Young W; Greene Y; Telfair J; Wang Y; Cramer W; Werner EM; Kenney K; Creary M; Grant AM
    Genet Med; 2015 Feb; 17(2):125-30. PubMed ID: 24991875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System.
    Baker JM; Nelson KN; Overton E; Lopman BA; Lash TL; Photakis M; Jacob JT; Roback JD; Fridkin SK; Steinberg JP
    Ann Intern Med; 2021 May; 174(5):649-654. PubMed ID: 33513035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States.
    Payne AB; Schieve LA; Abe K; Hulihan M; Hooper WC; Hsu LL
    Public Health Rep; 2022; 137(2):234-238. PubMed ID: 35060794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness.
    Wisk LE; Gottlieb MA; Spatz ES; Yu H; Wang RC; Slovis BH; Saydah S; Plumb ID; O'Laughlin KN; Montoy JCC; McDonald SA; Lin Z; Lin JS; Koo K; Idris AH; Huebinger RM; Hill MJ; Gentile NL; Chang AM; Anderson J; Hota B; Venkatesh AK; Weinstein RA; Elmore JG; Nichol G;
    JAMA Netw Open; 2022 Dec; 5(12):e2244486. PubMed ID: 36454572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying long-term effects of SARS-CoV-2 and their association with social determinants of health in a cohort of over one million COVID-19 survivors.
    Mukherjee S; Kshirsagar M; Becker N; Xu Y; Weeks WB; Patel S; Ferres JL; Jackson ML
    BMC Public Health; 2022 Dec; 22(1):2394. PubMed ID: 36539760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
    Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
    JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: A 12-month prospective cohort study.
    Konté K; Nur E; Tang MW; Heijmans J; van Tuijn CFJ; Biemond BJ
    Int J Lab Hematol; 2022 Apr; 44(2):e87-e90. PubMed ID: 34651455
    [No Abstract]   [Full Text] [Related]  

  • 40. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022.
    Qasmieh SA; Robertson MM; Teasdale CA; Kulkarni SG; Jones HE; McNairy M; Borrell LN; Nash D
    Prev Med; 2023 Apr; 169():107461. PubMed ID: 36813250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.